These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive review.
    Author: Miles D, Zielinski C, Martin M, Vrdoljak E, Robert N.
    Journal: Eur J Cancer; 2012 Mar; 48(4):482-91. PubMed ID: 22257791.
    Abstract:
    Both capecitabine and bevacizumab are established agents in the treatment of metastatic breast cancer, but until recently clinical data supporting their use in combination were limited. We review available data on the capecitabine-bevacizumab combination in breast cancer, particularly results from the RIBBON-1 trial in the first-line setting, and we discuss these findings in light of previous studies. We also examine ongoing trials investigating capecitabine-bevacizumab combination therapy.
    [Abstract] [Full Text] [Related] [New Search]